Efficacy and Safety of Acupuncture for Essential Hypertension: A Meta-Analysis

This 2018 meta-analysis represents one of the most comprehensive reviews of acupuncture in the treatment of essential hypertension, including 30 randomized clinical trials with 2,107 patients. The study investigated different acupuncture modalities, including manual acupuncture, electroacupuncture, and combinations with antihypertensive medications and lifestyle modifications. The investigators conducted a systematic search of multiple databases through April 2017, including PubMed, Embase, Cochrane Library, and Chinese databases, ensuring comprehensive coverage of the available literature. The methodology rigorously followed PRISMA guidelines and was registered with PROSPERO, ensuring transparency and reproducibility.

The acupuncture points most frequently used in the studies were LI-11 (Quchi), LR-3 (Taichong), GB-20 (Fengchi), ST-36 (Zusanli), and GV-20 (Baihui), reflecting traditional Chinese practice for the treatment of hypertension. The principal results showed that acupuncture combined with antihypertensive medications was significantly more effective than medications alone, producing additional reductions of 9.8 mmHg in systolic and 7.82 mmHg in diastolic blood pressure. Subgroup analysis revealed that this synergy was particularly evident when acupuncture was combined with calcium channel blockers. Interestingly, when compared on its own with antihypertensive medications, acupuncture showed similar but not superior efficacy, calling into question its appropriateness as monotherapy.

Comparison with sham acupuncture revealed no significant differences, raising questions about the specific mechanisms of action. In terms of safety, the few adverse events reported were mild, including local pain, minor bleeding, and occasionally dizziness, demonstrating an acceptable safety profile. However, the authors identified important limitations in the methodological quality of the included studies. Most showed a high risk of bias, particularly related to inadequate randomization, lack of appropriate blinding, and small sample sizes.

The quality analysis revealed significant differences between publications in English and Chinese, with the Chinese studies showing less methodological rigor. Substantial heterogeneity among studies (I²>50% in most analyses) suggests considerable variability in treatment protocols, selection criteria, and outcome measures. The findings have important clinical implications, suggesting that acupuncture may serve as a valuable adjunctive therapy in the management of hypertension, potentially allowing reduction of medication doses or better blood pressure control in patients with inadequate response to pharmacotherapy alone. The evidence of synergy with conventional medications supports an integrative approach to the treatment of hypertension.